ACTIVITY IN 2011
(Unaudited data)
CUMULATIVE ACTIVITY AS OF THE END OF DECEMBER 2011
thousands of euros
2010
2011
Variation at
current
exchange rates
Variation at
constant
exchange rates
France
279,052
292,181
+4.7%
+4.7%
International :
241,334
231,034
-4.3%
-3.5%
Incl. Europe excluding France
193,102
185,014
-4.2%
-4.0%
Incl. North America
41,819
38,416
-8.1%
-4.8%
Incl. Other countries
6,413
7,604
+18.6%
+18.5%
Group Total
520,386
523,215
+0.5%
+0.9%
thousands of euros
2010
2011
Variation at
current
exchange rates
Variation at
constant
exchange rates
Non-proprietary Homeopathic Medicines
267,460
265,636
-0.7%
-0.5%
OTC Specialties
251,985
257,748
+2.3%
+2.9%
Other
0,941
-0,169
-118.0%
-121.2%
Group Total
520,386
523,215
+0.5%
+0.9%
QUARTERLY ACTIVITY IN 2011 (variation at current rate)
1st Quarter
2nd Quarter
3rd Quarter
4th Quarter
thousands of euros
2010
2011
Var.
2010
2011
Var.
2010
2011
Var.
2010
2011
Var.
France
66,313
70,466
+6.3%
60,043
59,744
-0.5%
75,679
79,943
+5.6%
77,017
82,028
+6.5%
International :
55,047
58,478
+6.2%
40,129
37,128
-7.5%
71,139
67,885
-4.6%
75,019
67,543
-10.0%
Incl. Europe excluding France
44,854
47,024
+4.8%
31,223
28,880
-7.5%
58,806
55,013
-6.5%
58,219
54,097
-7.1%
Incl. North America
7,976
9,566
+19.9%
7,732
6,113
-20.9%
10,988
11,077
+0.8%
15,123
11,660
-22.9%
Incl. Other countries
2,217
1,888
-14.8%
1,174
2,135
+81.9%
1,345
1,795
+33.5%
1,677
1,786
+6.5%
Group Total
121,360
128,944
+6.3%
100,172
96,872
-3.3%
146,818
147,828
+0.7%
152,036
149,571
-1.6%
1st Quarter
2nd Quarter
3rd Quarter
4th Quarter
thousands of euros
2010
2011
Var.
2010
2011
Var.
2010
2011
Var.
2010
2011
Var.
Non-proprietary Homeopathic Medicines
67,467
69,371
+2.8%
64,246
62,414
-2.9%
64,979
63,246
-2.7%
70,768
70,605
-0.2%
OTC Specialties
53,683
59,417
+10.7%
35,744
34,499
-3.5%
81,711
84,645
+3.6%
80,847
79,187
-2.1%
Other
0,210
0,156
-25.7%
0,182
-0,041
-122.5%
0,128
-0,063
-149.2%
0,421
-0,221
-152.5%
Group Total
121,360
128,944
+6.3%
100,172
96,872
-3.3%
146,818
147,828
+0.7%
152,036
149,571
-1.6%
FOURTH QUARTER HIGHLIGHTS
On December 2, 2011, the French Supreme Court of Final Appeal definitively ended litigation related to the legality of the Additional Tax on Direct Sales opposing Boiron against the French Social Security Agency (URSSAF). The amount received by BOIRON in 2010 of €12,956 thousand has thereby been finalized as permanently acquired.
On December 29, 2011, a ministerial ordinance which modified the schedule of “authorized margins for pharmaceutical wholesalers” was published in the Official Journal, effective as of January 1, 2012. The new schedule permits price increases on several reimbursable medicines for the first time in 23 years.
Business activity in the fourth quarter decreased as compared to the fourth quarter of 2010:
Sales revenue in France increased by 6.5% thanks to the main specialties.
Sales decreased primarily in the USA, Poland and Russia.
The decision related to the Additional Tax on Direct Sales and favourable fourth quarter performance in France limited the decrease in full year profitability announced on October 20, 2011.
Next update: March 14th 2012, after the close of the stock market, publication of 2011 results.
Financial information manager: Philippe MONTANT
Contact for financial information: Véronique BOUSCAYROL
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at : www.boiron.com
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-26509-cp-boiron-260112.pdf
<!-- 90 -->
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
Quelle: Actusnews